PEEL Therapeutics
Salt Lake City
About PEEL Therapeutics
Peel Therapeutics is a clinical-stage biotech business that is creating drugs to improve the lives of patients. Peel (Hebrew for "elephant") began by focusing on cancer-fighting proteins in elephants, and we rapidly realized the power of leveraging evolution's answers to treat and prevent disease. In addition to producing elephant p53 (EP53) nanoparticles for cancer treatment, our team is expanding new cancer and inflammation medicines derived from nature's superpowers.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $25.1M
- Funding stage: Early Stage Venture
- Last round: Series A (Feb 2025)
- Website: peeltx.com
- Phone: 650-464-0747
Industries & Categories
Biotechnology
Canonical: https://fsome.com/organization/peel-therapeutics-31423 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.